{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:27:10Z","timestamp":1790519230885,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"My Oncology Dream award 2014"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s10549-017-4463-6","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T06:16:26Z","timestamp":1503382586000},"page":"819-832","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Thrombocytosis as a prognostic factor in inflammatory breast cancer"],"prefix":"10.1007","volume":"166","author":[{"given":"Kenichi","family":"Harano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan N.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bora","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Reuben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto T.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"key":"4463_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","volume":"65","author":"RL Siegel","year":"2015","unstructured":"Siegel RL, Miller KD, Jemal A (2015) Cancer statistics, 2015. CA Cancer J Clin 65:5\u201329","journal-title":"CA Cancer J Clin"},{"key":"4463_CR2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747\u2013752","journal-title":"Nature"},{"key":"4463_CR3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1470-2045(12)70209-7","volume":"13","author":"A Lucci","year":"2012","unstructured":"Lucci A, Hall CS, Lodhi AK et al (2012) Circulating tumour cells in non-metastatic breast cancer: a prospective study. Lancet Oncol 13:688\u2013695","journal-title":"Lancet Oncol"},{"key":"4463_CR4","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1182\/blood-2007-04-083501","volume":"110","author":"A Tefferi","year":"2007","unstructured":"Tefferi A, Thiele J, Orazi A et al (2007) Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 110:1092\u20131097","journal-title":"Blood"},{"key":"4463_CR5","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1001\/jama.1970.03170110058017","volume":"211","author":"SE Silvis","year":"1970","unstructured":"Silvis SE, Turkbas N, Doscherholmen A (1970) Thrombocytosis in patients with lung cancer. JAMA 211:1852\u20131853","journal-title":"JAMA"},{"key":"4463_CR6","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1055\/s-0037-1615093","volume":"79","author":"M Monreal","year":"1998","unstructured":"Monreal M, Fernandez-Llamazares J, Pinol M et al (1998) Platelet count and survival in patients with colorectal cancer\u2013a preliminary study. Thromb Haemost 79:916\u2013918","journal-title":"Thromb Haemost"},{"key":"4463_CR7","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA et al (2012) Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med 366:610\u2013618","journal-title":"N Engl J Med"},{"key":"4463_CR8","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1586\/14737140.8.8.1247","volume":"8","author":"L Borsig","year":"2008","unstructured":"Borsig L (2008) The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8:1247\u20131255","journal-title":"Expert Rev Anticancer Ther"},{"key":"4463_CR9","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1055\/s-0037-1613413","volume":"89","author":"S Taucher","year":"2003","unstructured":"Taucher S, Salat A, Gnant M et al (2003) Impact of pretreatment thrombocytosis on survival in primary breast cancer. Thromb Haemost 89:1098\u20131106","journal-title":"Thromb Haemost"},{"key":"4463_CR10","first-page":"4545","volume":"33","author":"A Rajkumar","year":"2013","unstructured":"Rajkumar A, Szallasi A (2013) Paraneoplastic thrombocytosis in breast cancer. Anticancer Res 33:4545\u20134546","journal-title":"Anticancer Res"},{"key":"4463_CR11","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnci\/dji172","volume":"97","author":"KW Hance","year":"2005","unstructured":"Hance KW, Anderson WF, Devesa SS et al (2005) Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute. J Natl Cancer Inst 97:966\u2013975","journal-title":"J Natl Cancer Inst"},{"key":"4463_CR12","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10549-015-3436-x","volume":"152","author":"TM Fouad","year":"2015","unstructured":"Fouad TM, Kogawa T, Liu DD et al (2015) Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis. Breast Cancer Res Treat 152:407\u2013416","journal-title":"Breast Cancer Res Treat"},{"key":"4463_CR13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/annonc\/mdq345","volume":"22","author":"S Dawood","year":"2011","unstructured":"Dawood S, Merajver SD, Viens P et al (2011) International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment. Ann Oncol 22:515\u2013523","journal-title":"Ann Oncol"},{"key":"4463_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-3-0348-0837-8_3","volume":"816","author":"TM Fouad","year":"2014","unstructured":"Fouad TM, Kogawa T, Reuben JM, Ueno NT (2014) The role of inflammation in inflammatory breast cancer. Adv Exp Med Biol 816:53\u201373","journal-title":"Adv Exp Med Biol"},{"key":"4463_CR15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/sj.neo.7900115","volume":"2","author":"KL Golen van","year":"2000","unstructured":"van Golen KL, Wu ZF, Qiao XT et al (2000) RhoC GTPase overexpression modulates induction of angiogenic factors in breast cells. Neoplasia 2:418\u2013425","journal-title":"Neoplasia"},{"key":"4463_CR16","doi-asserted-by":"crossref","first-page":"4380","DOI":"10.1158\/0008-5472.CAN-11-0308","volume":"71","author":"ZC Hartman","year":"2011","unstructured":"Hartman ZC, Yang XY, Glass O et al (2011) HER2 overexpression elicits a proinflammatory IL-6 autocrine signaling loop that is critical for tumorigenesis. Can Res 71:4380\u20134391","journal-title":"Can Res"},{"key":"4463_CR17","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3816\/CBC.2002.n.008","volume":"2","author":"I Benoy","year":"2002","unstructured":"Benoy I, Salgado R, Colpaert C et al (2002) Serum interleukin 6, plasma VEGF, serum VEGF, and VEGF platelet load in breast cancer patients. Clin Breast Cancer 2:311\u2013315","journal-title":"Clin Breast Cancer"},{"key":"4463_CR18","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.1182\/blood-2007-12-130120","volume":"111","author":"A Ferrajoli","year":"2008","unstructured":"Ferrajoli A, Lee BN, Schlette EJ et al (2008) Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia. Blood 111:5291\u20135297","journal-title":"Blood"},{"key":"4463_CR19","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","volume":"19","author":"DF Quail","year":"2013","unstructured":"Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423\u20131437","journal-title":"Nat Med"},{"key":"4463_CR20","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/bjc.2015.183","volume":"113","author":"CH Koh","year":"2015","unstructured":"Koh CH, Bhoo-Pathy N, Ng KL et al (2015) Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer 113:150\u2013158","journal-title":"Br J Cancer"},{"key":"4463_CR21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1245\/s10434-011-1814-0","volume":"19","author":"B Azab","year":"2012","unstructured":"Azab B, Bhatt VR, Phookan J et al (2012) Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients. Ann Surg Oncol 19:217\u2013224","journal-title":"Ann Surg Oncol"},{"key":"4463_CR22","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/carcin\/bgu247","volume":"36","author":"X Liu","year":"2015","unstructured":"Liu X, Meng QH, Ye Y et al (2015) Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis 36:243\u2013248","journal-title":"Carcinogenesis"},{"key":"4463_CR23","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1158\/1078-0432.CCR-12-1397","volume":"18","author":"JE Brown","year":"2012","unstructured":"Brown JE, Cook RJ, Lipton A, Coleman RE (2012) Serum lactate dehydrogenase is prognostic for survival in patients with bone metastases from breast cancer: a retrospective analysis in bisphosphonate-treated patients. Clin Cancer Res 18:6348\u20136355","journal-title":"Clin Cancer Res"},{"key":"4463_CR24","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jama.2011.124","volume":"305","author":"LJ Horsfall","year":"2011","unstructured":"Horsfall LJ, Rait G, Walters K et al (2011) Serum bilirubin and risk of respiratory disease and death. JAMA 305:691\u2013697","journal-title":"JAMA"},{"key":"4463_CR25","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-3148.2001.00340.x","volume":"11","author":"F Boehlen","year":"2001","unstructured":"Boehlen F, Clemetson KJ (2001) Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med 11:403\u2013417","journal-title":"Transfus Med"},{"key":"4463_CR26","first-page":"RA87-90","volume":"13","author":"C Bechara","year":"2007","unstructured":"Bechara C, Chai H, Lin PH et al (2007) Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Med Sci Monit 13:RA87-90","journal-title":"Med Sci Monit"},{"key":"4463_CR27","doi-asserted-by":"crossref","first-page":"5951","DOI":"10.1158\/1078-0432.CCR-06-0736","volume":"12","author":"Y Wen","year":"2006","unstructured":"Wen Y, Giardina SF, Hamming D et al (2006) GROalpha is highly expressed in adenocarcinoma of the colon and down-regulates fibulin-1. Clin Cancer Res 12:5951\u20135959","journal-title":"Clin Cancer Res"},{"key":"4463_CR28","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1038\/sj.onc.1203687","volume":"19","author":"E Loukinova","year":"2000","unstructured":"Loukinova E, Dong G, Enamorado-Ayalya I et al (2000) Growth regulated oncogene-alpha expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC receptor-2 dependent mechanism. Oncogene 19:3477\u20133486","journal-title":"Oncogene"},{"key":"4463_CR29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2141.2008.07428.x","volume":"144","author":"JP Salim","year":"2009","unstructured":"Salim JP, Goette NP, Lev PR et al (2009) Dysregulation of stromal derived factor 1\/CXCR4 axis in the megakaryocytic lineage in essential thrombocythemia. Br J Haematol 144:69\u201377","journal-title":"Br J Haematol"},{"key":"4463_CR30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ctrv.2013.09.008","volume":"40","author":"P Mallini","year":"2014","unstructured":"Mallini P, Lennard T, Kirby J, Meeson A (2014) Epithelial-to-mesenchymal transition: what is the impact on breast cancer stem cells and drug resistance. Cancer Treat Rev 40:341\u2013348","journal-title":"Cancer Treat Rev"},{"key":"4463_CR31","doi-asserted-by":"crossref","first-page":"e0132710","DOI":"10.1371\/journal.pone.0132710","volume":"10","author":"EN Cohen","year":"2015","unstructured":"Cohen EN, Gao H, Anfossi S et al (2015) Inflammation mediated metastasis: immune induced epithelial-to-mesenchymal transition in inflammatory breast cancer cells. PLoS ONE 10:e0132710","journal-title":"PLoS ONE"},{"key":"4463_CR32","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1158\/1078-0432.CCR-12-2549","volume":"19","author":"SJ Laere Van","year":"2013","unstructured":"Van Laere SJ, Ueno NT, Finetti P et al (2013) Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasets. Clin Cancer Res 19:4685\u20134696","journal-title":"Clin Cancer Res"},{"key":"4463_CR33","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO (2011) Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell 20:576\u2013590","journal-title":"Cancer Cell"},{"key":"4463_CR34","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.1182\/blood-2012-06-438598","volume":"120","author":"MS Cho","year":"2012","unstructured":"Cho MS, Bottsford-Miller J, Vasquez HG et al (2012) Platelets increase the proliferation of ovarian cancer cells. Blood 120:4869\u20134872","journal-title":"Blood"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10549-017-4463-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4463-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10549-017-4463-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T13:21:38Z","timestamp":1570022498000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10549-017-4463-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["4463"],"URL":"https:\/\/doi.org\/10.1007\/s10549-017-4463-6","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"value":"0167-6806","type":"print"},{"value":"1573-7217","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]}}}